InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
0.8987
+0.0562 (6.66%)
Sep 4, 2026, 11:46 AM EDT - Market open
InspireMD Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -52.48 | -48.79 | -32.01 | -19.92 | -18.49 | -14.92 |
Depreciation & Amortization | 0.58 | 0.48 | 0.28 | 0.23 | 0.19 | 0.16 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | - | -0.01 | - | -0 |
Loss (Gain) From Sale of Investments | -0.2 | -0.36 | -0.89 | -0.74 | - | - |
Stock-Based Compensation | 10.72 | 12.33 | 10.14 | 4.49 | 2.35 | 1.58 |
Other Operating Activities | -0.15 | 0.14 | -0.12 | 0.36 | 0.01 | 0.03 |
Change in Accounts Receivable | -0.22 | -0.6 | 0.23 | -0.77 | 0.19 | -0.75 |
Change in Inventory | 0.35 | -0.83 | -0.46 | -0.49 | -0.48 | 0.27 |
Change in Accounts Payable | 0.14 | 0 | 0.32 | 0.28 | -0.23 | 0.66 |
Change in Other Net Operating Assets | 0.08 | 2.53 | 0.65 | 0.17 | 0.92 | -0.24 |
Operating Cash Flow | -41.21 | -35.1 | -21.87 | -16.38 | -15.54 | -13.21 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.25 | -1.66 | -1.4 | -0.38 | -0.47 | -0.34 |
Sale of Property, Plant & Equipment | 0.02 | 0.02 | - | 0.01 | - | - |
Investment in Securities | -7.2 | -29.19 | 14.13 | -15.64 | 9 | -22 |
Other Investing Activities | 0.29 | 0.28 | -0.09 | -0.08 | -0.09 | -0.11 |
Investing Cash Flow | -8.15 | -30.56 | 12.64 | -16.09 | 8.44 | -22.46 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Issuance of Common Stock | 52.9 | 55.57 | 18.53 | 42.17 | - | 37.06 |
Other Financing Activities | 0.02 | - | -0.08 | -4.64 | -0.14 | -2.02 |
Financing Cash Flow | 52.93 | 55.57 | 18.45 | 37.53 | -0.14 | 35.03 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.08 | 0.12 | 0.05 | -0.06 | -0.13 | -0.01 |
Net Cash Flow | 3.64 | -9.98 | 9.28 | 5.01 | -7.37 | -0.64 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -42.46 | -36.77 | -23.27 | -16.76 | -16.02 | -13.55 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -391.67% | -409.45% | -332.00% | -270.06% | -309.71% | -301.54% |
Free Cash Flow Per Share | -0.52 | -0.57 | -0.56 | -0.69 | -2.03 | -1.84 |
Levered Free Cash Flow | -23.11 | -18.73 | -11 | -9.67 | -9.37 | -7.64 |
Unlevered Free Cash Flow | -23.11 | -18.73 | -11 | -9.67 | -9.37 | -7.54 |